Previous Close | 0.2000 |
Open | 0.2100 |
Bid | 0.2000 x N/A |
Ask | 0.2050 x N/A |
Day's Range | 0.2050 - 0.2100 |
52 Week Range | 0.1950 - 0.4500 |
Volume | |
Avg. Volume | 90,366 |
Market Cap | 23.711M |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - May 11, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce the Company's first US demonstration trial on stone fruit, with a conventional cherry grower in Washington. The trial began during the mid-April bloom period and will continue through summer harvest.The United States is the world's second-largest cherry producer, second only to Turkey,
Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - April 27, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce the Company has submitted its proprietary Clonostachys rosea CR-7 (CR-7) biological fungicide for registration in Mexico. The registration dossier was presented on April 19, 2022 at a meeting with COFEPRIS (The Federal Commission for Protection from Sanitary Risks), the Mexican healt
Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - April 20, 2022) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") is pleased to announce positive progress in 2022 sales commitments from US growers. In just seven months into the fiscal year, the Company has invoiced growers in the Southeast region and secured commitments in the Northeast, Midwest, and Pacific Northwest - already increasing total sales year-over-year by